819 related articles for article (PubMed ID: 24525294)
1. Roflumilast N-oxide inhibits bronchial epithelial to mesenchymal transition induced by cigarette smoke in smokers with COPD.
Milara J; Peiró T; Serrano A; Guijarro R; Zaragozá C; Tenor H; Cortijo J
Pulm Pharmacol Ther; 2014 Aug; 28(2):138-48. PubMed ID: 24525294
[TBL] [Abstract][Full Text] [Related]
2. Simvastatin Increases the Ability of Roflumilast N-oxide to Inhibit Cigarette Smoke-Induced Epithelial to Mesenchymal Transition in Well-differentiated Human Bronchial Epithelial Cells in vitro.
Milara J; Peiró T; Serrano A; Artigues E; Aparicio J; Tenor H; Sanz C; Cortijo J
COPD; 2015 Jun; 12(3):320-31. PubMed ID: 25207459
[TBL] [Abstract][Full Text] [Related]
3. Epithelial to mesenchymal transition is increased in patients with COPD and induced by cigarette smoke.
Milara J; Peiró T; Serrano A; Cortijo J
Thorax; 2013 May; 68(5):410-20. PubMed ID: 23299965
[TBL] [Abstract][Full Text] [Related]
4. Roflumilast N-oxide, a PDE4 inhibitor, improves cilia motility and ciliated human bronchial epithelial cells compromised by cigarette smoke in vitro.
Milara J; Armengot M; Bañuls P; Tenor H; Beume R; Artigues E; Cortijo J
Br J Pharmacol; 2012 Aug; 166(8):2243-62. PubMed ID: 22385203
[TBL] [Abstract][Full Text] [Related]
5. Roflumilast partially reverses smoke-induced mucociliary dysfunction.
Schmid A; Baumlin N; Ivonnet P; Dennis JS; Campos M; Krick S; Salathe M
Respir Res; 2015 Oct; 16():135. PubMed ID: 26521141
[TBL] [Abstract][Full Text] [Related]
6. Roflumilast N-oxide prevents cytokine secretion induced by cigarette smoke combined with LPS through JAK/STAT and ERK1/2 inhibition in airway epithelial cells.
Victoni T; Gleonnec F; Lanzetti M; Tenor H; Valença S; Porto LC; Lagente V; Boichot E
PLoS One; 2014; 9(1):e85243. PubMed ID: 24416369
[TBL] [Abstract][Full Text] [Related]
7. Roflumilast combined with adenosine increases mucosal hydration in human airway epithelial cultures after cigarette smoke exposure.
Tyrrell J; Qian X; Freire J; Tarran R
Am J Physiol Lung Cell Mol Physiol; 2015 May; 308(10):L1068-77. PubMed ID: 25795727
[TBL] [Abstract][Full Text] [Related]
8. The preclinical pharmacology of roflumilast--a selective, oral phosphodiesterase 4 inhibitor in development for chronic obstructive pulmonary disease.
Hatzelmann A; Morcillo EJ; Lungarella G; Adnot S; Sanjar S; Beume R; Schudt C; Tenor H
Pulm Pharmacol Ther; 2010 Aug; 23(4):235-56. PubMed ID: 20381629
[TBL] [Abstract][Full Text] [Related]
9. Cigarette smoke-induced disruption of bronchial epithelial tight junctions is prevented by transforming growth factor-β.
Schamberger AC; Mise N; Jia J; Genoyer E; Yildirim AÖ; Meiners S; Eickelberg O
Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1040-52. PubMed ID: 24358952
[TBL] [Abstract][Full Text] [Related]
10. Roflumilast improves corticosteroid resistance COPD bronchial epithelial cells stimulated with toll like receptor 3 agonist.
Milara J; Morell A; Ballester B; Sanz C; Freire J; Qian X; Alonso-Garcia M; Morcillo E; Cortijo J
Respir Res; 2015 Feb; 16(1):12. PubMed ID: 25652132
[TBL] [Abstract][Full Text] [Related]
11. Phosphodiesterase 4 inhibitors augment the ability of formoterol to enhance glucocorticoid-dependent gene transcription in human airway epithelial cells: a novel mechanism for the clinical efficacy of roflumilast in severe chronic obstructive pulmonary disease.
Moodley T; Wilson SM; Joshi T; Rider CF; Sharma P; Yan D; Newton R; Giembycz MA
Mol Pharmacol; 2013 Apr; 83(4):894-906. PubMed ID: 23389862
[TBL] [Abstract][Full Text] [Related]
12. Phosphodiesterase-4 inhibition augments human lung fibroblast vascular endothelial growth factor production induced by prostaglandin E2.
Ikari J; Michalski JM; Iwasawa S; Gunji Y; Nogel S; Park JH; Nelson AJ; Farid M; Wang X; Schulte N; Basma H; Toews ML; Feghali-Bostwick C; Tenor H; Liu X; Rennard SI
Am J Respir Cell Mol Biol; 2013 Oct; 49(4):571-81. PubMed ID: 23656623
[TBL] [Abstract][Full Text] [Related]
13. Posttranscriptional silencing of the lncRNA MALAT1 by miR-217 inhibits the epithelial-mesenchymal transition via enhancer of zeste homolog 2 in the malignant transformation of HBE cells induced by cigarette smoke extract.
Lu L; Luo F; Liu Y; Liu X; Shi L; Lu X; Liu Q
Toxicol Appl Pharmacol; 2015 Dec; 289(2):276-85. PubMed ID: 26415832
[TBL] [Abstract][Full Text] [Related]
14. Roflumilast N-oxide reverses corticosteroid resistance in neutrophils from patients with chronic obstructive pulmonary disease.
Milara J; Lluch J; Almudever P; Freire J; Xiaozhong Q; Cortijo J
J Allergy Clin Immunol; 2014 Aug; 134(2):314-22. PubMed ID: 24636089
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid Receptor α Mediates Roflumilast's Ability to Restore Dexamethasone Sensitivity in COPD.
Reddy AT; Lakshmi SP; Banno A; Reddy RC
Int J Chron Obstruct Pulmon Dis; 2020; 15():125-134. PubMed ID: 32021151
[TBL] [Abstract][Full Text] [Related]
16. Role of aberrant WNT signalling in the airway epithelial response to cigarette smoke in chronic obstructive pulmonary disease.
Heijink IH; de Bruin HG; van den Berge M; Bennink LJ; Brandenburg SM; Gosens R; van Oosterhout AJ; Postma DS
Thorax; 2013 Aug; 68(8):709-16. PubMed ID: 23370438
[TBL] [Abstract][Full Text] [Related]
17. Imprinting of the COPD airway epithelium for dedifferentiation and mesenchymal transition.
Gohy ST; Hupin C; Fregimilicka C; Detry BR; Bouzin C; Gaide Chevronay H; Lecocq M; Weynand B; Ladjemi MZ; Pierreux CE; Birembaut P; Polette M; Pilette C
Eur Respir J; 2015 May; 45(5):1258-72. PubMed ID: 25745049
[TBL] [Abstract][Full Text] [Related]
18. [Wood smoke condensate induced epithelial-mesenchymal transition in human airway epithelial cells].
Li W; Zou W; Li B; Ran P
Zhonghua Jie He He Hu Xi Za Zhi; 2014 Jan; 37(1):24-9. PubMed ID: 24694970
[TBL] [Abstract][Full Text] [Related]
19. Carbocysteine regulates innate immune responses and senescence processes in cigarette smoke stimulated bronchial epithelial cells.
Pace E; Ferraro M; Siena L; Scafidi V; Gerbino S; Di Vincenzo S; Gallina S; Lanata L; Gjomarkaj M
Toxicol Lett; 2013 Nov; 223(2):198-204. PubMed ID: 24076166
[TBL] [Abstract][Full Text] [Related]
20. Combined inhibition of PDE4 and PI3Kδ modulates the inflammatory component involved in the progression of chronic obstructive pulmonary disease.
Dinavahi SS; Nyayapathy S; Perumal Y; Dharmarajan S; Viswanadha S
Drug Res (Stuttg); 2014 Apr; 64(4):214-9. PubMed ID: 24105104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
